7-30595148-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002047.4(GARS1):​c.222+5C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000723 in 1,383,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

GARS1
NM_002047.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00008123
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00800

Publications

0 publications found
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1-DT (HGNC:48951): (GARS1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002047.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GARS1
NM_002047.4
MANE Select
c.222+5C>G
splice_region intron
N/ANP_002038.2P41250-1
GARS1
NM_001316772.1
c.60+5C>G
splice_region intron
N/ANP_001303701.1P41250-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GARS1
ENST00000389266.8
TSL:1 MANE Select
c.222+5C>G
splice_region intron
N/AENSP00000373918.3P41250-1
GARS1
ENST00000675651.1
c.222+5C>G
splice_region intron
N/AENSP00000502513.1A0A6Q8PGZ8
GARS1
ENST00000675810.1
c.222+5C>G
splice_region intron
N/AENSP00000502743.1A0A6Q8PHH9

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.23e-7
AC:
1
AN:
1383866
Hom.:
0
Cov.:
35
AF XY:
0.00
AC XY:
0
AN XY:
683002
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31586
American (AMR)
AF:
0.00
AC:
0
AN:
35714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25168
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35772
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79208
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5628
European-Non Finnish (NFE)
AF:
9.27e-7
AC:
1
AN:
1078170
Other (OTH)
AF:
0.00
AC:
0
AN:
57868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
13
DANN
Benign
0.85
PhyloP100
0.0080
PromoterAI
0.11
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000081
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072236; hg19: chr7-30634764; API